New FDA Policies Could Limit the Full Value of AI in Medicine

Scott Gottlieb

JAMA Health Forum . 2025 Feb 7;6(2):e250289. doi: 10.1001/jamahealthforum.2025.0289.

Summary

This JAMA Forum discusses the ways in which recent changes to US Food and Drug Administration (FDA) policies related to the regulation of artificial intelligence (AI) have added new uncertainties for the use of AI tools in medicine.